Metraipolis › archive › dc_5d645b8943fe
SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study — Europe PMC PMID:41876457
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41876457
- DOI
- 10.1038/s41398-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T01:19:48.857Z
- SHA-256 of the archived text
d43f03c043e478e7d3e3123179443da5630312d6a82544de628a1e42f5fed2f3- Stable URL of this page
https://metraipolis.com/documento/dc_5d645b8943fe
How to cite
SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study — Europe PMC PMID:41876457 — Europe PMC (en), https://europepmc.org/article/MED/41876457 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5d645b8943fe (Metraipolis archive dc_5d645b8943fe, sha256 d43f03c043e478e7d3e3123179443da5630312d6a82544de628a1e42f5fed2f3)
BibTeX
@misc{dc5d645b8943fe,
title = {SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study — Europe PMC PMID:41876457},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41876457},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5d645b8943fe; sha256 d43f03c043e478e7d3e3123179443da5630312d6a82544de628a1e42f5fed2f3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41876457. Agents can read the archived copy with the MCP tool read_document.